Doxepin for insomnia: A systematic review of randomized placebo-controlled trials
- 1 February 2015
- journal article
- review article
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 19, 75-83
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy and safety of doxepin 6 mg in a model of transient insomniaSleep Medicine, 2010
- British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersJournal of Psychopharmacology, 2010
- Low-Dose DoxepinCNS Drugs, 2010
- Antidepressants and Sleep: A ReviewPerspectives in Psychiatric Care, 2009
- Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary InsomniaThe Journal of Clinical Psychiatry, 2008
- Industry-sponsored researchInjury, 2008
- The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTsJournal of General Internal Medicine, 2007
- Pharmacologic and Nonpharmacologic Treatments of InsomniaNeurologic Clinics, 2005
- Doxepin in the Treatment of Primary InsomniaThe Journal of Clinical Psychiatry, 2001
- Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitorsActa Psychiatrica Scandinavica, 2000